SCHEMBL14765644

SCHEMBL14765644

COC(=O)Cc1ccc2[nH]c(COc3ccc(Cl)cc3Cl)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
RHEB Q15382 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C19 P33261 1/20 0.47
MAPT P10636 3/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
KMT2A Q03164 1/20 0.46
MRGPRX4 Q96LA9 6/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
BRS3 P32247 1/20 0.44
S1PR4 O95977 1/20 0.43
ADRB2 P07550 1/20 0.43
NTRK1 P04629 1/20 0.42
NTRK2 Q16620 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3148681 0.83 MRGPRX4 (0.52) NPC1RAB9ARHEBCYP1A2CYP3A4
SCHEMBL3152589 0.80 RAB9A (0.57) NPC1RAB9ARHEBMAPTHSD17B10
SCHEMBL23709934 0.79 RHEB (0.63) RHEBMAPTHSD17B10MRGPRX4KDM4E
SCHEMBL3143457 0.79 ALDH1A1 (0.53) NPC1RAB9ARHEBCYP1A2CYP3A4
SCHEMBL14765645 0.78 NPC1 (0.47) NPC1RAB9ACYP1A2CYP3A4CYP2C19
SCHEMBL7689491 0.76 RAB9A (0.60) NPC1RAB9ARHEBMAPTHSD17B10
SCHEMBL20424542 0.76 SMN1; SMN2 (0.47) NPC1RAB9AMAPTHSD17B10MEN1
SCHEMBL2242937 0.75 RAB9A (0.70) NPC1RAB9AMAPTHSD17B10MEN1
SCHEMBL3153713 0.73 RAB9A (0.57) NPC1RAB9ARHEBMAPTHSD17B10
SCHEMBL23589337 0.72 SMN1; SMN2 (0.45) NPC1RAB9AMAPTHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394799-B2 Compounds that inhibit HIF-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2013-03-12 US disclosed